Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL3540827 | 0.93 | HDAC8 (0.33) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Sulfuric Acid SCHEMBL3540830 | 0.93 | HDAC8 (0.33) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Hydrochloric Acid SCHEMBL3171274 | 0.85 | HDAC8 (0.38) | KDM4ENPC1PABPC1APOBEC3ARAB9A | |
| Sulfuric Acid SCHEMBL2866335 | 0.70 | HDAC8 (0.42) | KDM4EAPOBEC3AAPOBEC3GHDAC8HTT | |
| Sulfuric Acid SCHEMBL3398193 | 0.70 | KDM4E (0.34) | KDM4EHTT | |
| Sulfuric Acid SCHEMBL21195041 | 0.67 | APOBEC3A (0.44) | KDM4EAPOBEC3AAPOBEC3GHDAC8HTT | |
| Sulfuric Acid SCHEMBL17102586 | 0.67 | HDAC8 (0.38) | KDM4EAPOBEC3AAPOBEC3GHDAC8HTT | |
| Sulfuric Acid SCHEMBL1293162 | 0.66 | MAPT (0.34) | NPC1RAB9AHDAC8HTT | |
| Sulfuric Acid SCHEMBL21195036 | 0.65 | HTT (0.47) | KDM4EAPOBEC3AAPOBEC3GHDAC8HTT | |
| Sulfuric Acid SCHEMBL5598595 | 0.63 | USP2 (0.35) | KDM4EPABPC1RAB9AHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723522-B2 | Pyridine derivative production method | FUJIFILM FINECHEMICALS CO., LTD (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-1559711-B1 | PREPARATION OF PYRIDINE DERIVATIVES USING PYRIMIDINIUM DERIVATIVES AS INTERMEDIATES | FUJIFILM FINECHEMICALS CO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20050171355-A1 | Pyridine derivative production method | SANKIO CHEMICAL CO., LTD. | 2005-08-04 | — | — | US | disclosed |
| EP-1559711-A1 | PREPARATION OF PYRIDINE DERIVATIVES USING PYRIMIDINIUM DERIVATIVES AS INTERMEDIATES | Sankio Chemical Co., Ltd. (JP) | 2005-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171355-A1 | Pyridine derivative production method | CPS1, NAT1, ACMSD | KDM4E 779/4885NPC1 3394/4885PABPC1 1628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.